Samuel Nussbaum Email and Phone Number

As a Senior clinical research coordinator in the Early Cancer Therapeutics pod, I kept 50% of my role as a clinical research coordinator, with the other 50% of my role being focused on the below added responsibilities:•Developing and managing all new studies in our portfolio from study startup, site logistics and initiation, through to activation from the coordinator perspective•Mentoring of new clinical research coordinators on responsibilities of a coordinator from study development, implementation/activation, and closing activities as well as pod-specific processes•Building/editing of protocols for Investigator Initiated Trials during protocol development and modification at our site

• Worked as the lead coordinator on many greater than minimal risk Phase 1a/1b dose escalation/dose expansion clinical trials in the Early Cancer Therapeutics pod.• Coordinated contact for our site between the patients, oncologists, sponsors, and monitors of each study.• Explained risks, benefits, and other aspects of clinical trials to potential participants as a part of the ongoing process of consent.• Ensured potential participants of the trial met the eligibility requirements and made sure they adhered to the schedule as required by the protocol once becoming active on study.• Recorded patients journey throughout the stages of the clinical trials using ALCOA+ documentation practices.• Entered data, reported adverse events/safety information, and answered queries in the electronic data capture (EDC) and lab portals.• Prepared studies for upcoming audits and continuing reviews, making sure that all deviations and adverse events are reported appropriately.• Collaborated with research team to determine logistics and feasibility of new clinical trials hoping to be opened at our site.

• Study personnel assigned to Phase 1b/II clinical trial studies section of laboratory.• Responsibilities consisted of bio-specimen processing and storage of sera, plasma, and peripheral blood mononuclear cells (PBMCs) in a biosafety level 2 (BLS-2) environment using aseptic technique.

• Worked on many research studies in the Vascular/General Surgery Department.• Responsible for training new personnel, coordinating with multiple departments, leading research meetings, and observing relevant surgeries.• Assisted in writing portions of an Investigational New Drug (IND) proposal to the FDA.• Collected data for multiple projects that involved analyzing non-contrast enhanced CT scans to determine the degree of calcification in the aortic, iliac, and renal arteries and kidneys.• Conducted tests on patients for several prospective studies. • Wrote or co-wrote multiple manuscripts that have been submitted to journals and are awaiting publication.

• Worked on several research studies in the Vascular Surgery Department.• Responsible for training new personnel, coordinating with multiple departments, leading research meetings, and observing relevant surgeries.• Reviewed scientific literature to assist in the writing of an IND proposal.• Helped write a letter of intent grant proposal for funding on a study.• Trained to use ultrasound/ECG to take images of the carotid and aortic artery and analyze the stress and strain on the arteries. • Wrote and submitted multiple proposals to Mayo Clinic Institutional Review Board for approval of new research projects.

• Under the supervision of Dr. Houssam Farres, assisted with data collection for a research project regarding hyperglycemia and its potential effects on patients undergoing vascular surgery.• Shadowed Dr. Farres during clinical rotation and in surgery.• Observed medical scenarios and surgical training techniques in the Multidisciplinary Simulation Center